This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This pharmaphorum webinar, held in association with Savana, will take place on Thursday 22 April from 16:00-17:00 BST / 17:00-18:00 CET / 10:00-11:00 EST and hear from presenters at BREATHE – the health dataresearch hub for respiratory health, Salford Royal NHS Foundation Trust and Savana.
Opportunities are growing for real-world evidence research as the technology matures and a pioneering new partnership between Savana, utilising its AI-driven clinicalresearch methodology, and BREATHE aims to drive innovative research using this new way of working. The benefits of RWE. Patient-friendly studies.
The Indian life sciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, bigdata, internet of things (IoT) and blockchain into their research and development efforts.
If you hadn’t already noticed, the clinicalresearch enterprise has well and truly entered the era of “bigdata,” artificial intelligence (AI), and machine learning. As a result, the time required to design, launch, and execute high-impact clinicaltrials is significantly reduced.”
Countries like Estonia and Finland have taken on a completely digitised approach to their health services , integrating EHR data to efficiently prescribe medications and improve treatment strategies. Darwin EU is part of the EMA BigData Steering group that aims to increase the utility of BigData in regulatory decision-making.
Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s BigData Institute. ElZarrad is the director of the Office of Medical Policy in the FDA’s Center for Drug Evaluation and Research. Join the online meeting.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
Just in time to help recognize Pride Month , ACRP’s ClinicalResearcher journal is pleased to share the first details from the lead peer-reviewed article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the new issue going online today (June 13).
Just in time to help recognize Pride Month , ACRP’s ClinicalResearcher journal is pleased to share the first details from the lead peer-reviewed article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the new issue going online today (June 13).
Just in time to help recognize Pride Month , ACRP’s ClinicalResearcher journal is pleased to share the first details from the lead peer-reviewed article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the new issue going online today (June 13).
Some of the medical advances with the technology are genomics and epigenetics, BigData, AI and ML which are allowing molecular […] Technology adoptions like artificial intelligence and machine learning are bringing in major transformation in the way a primary physician will extend treatment protocols.
Pérez-Stable, MD This year’s annual Steering Committee meeting for the NIH Pragmatic Trials Collaboratory featured health equity as a central topic of discussion. Going forward, there is also tremendous value in capturing more granular data on individuals’ heritage and background.
Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes.
A paradigm shift is occurring in the clinicaltrials industry surrounding mobile technology, or more specifically, mobile health (mHealth) following the COVID-19 pandemic. Organizations are beginning to recognize the power mHealth has to positively affect their clinicaltrials and are implementing technologies at an increasing rate.
We know that the demand at the site level for studies is growing and the workforce capacity is shrinking, notes Bree Burks, RN, MSN, Vice President of Strategy for Veeva Systems, who will present on The ClinicalResearch Technology Reboot: Are We Getting it Right? The ClinicalResearch Technology Reboot: Are We Getting it Right?
a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinicaltrial enrollment, announced today it has launched its SYNERGY-AI Oncology ClinicalTrial Command Center (OCTCC) with the mission to disrupt and accelerate the clinicaltrial enrollment process.
It was a time when “the potential for systematic understanding of complex biology was palpable”, a fascinating terrain wherein the “first bacterial genomes were being sequenced”, when microarray technology was in the early stages of being invented, and ‘genomics’ and ‘bigdata’ certainly weren’t on the tips of people’s tongues.
A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinicaltrials submitted in support of new marketing application along with the usual structured analyses from sponsors.
Clinicaltrials are prospective biomedical research studies designed to evaluate medical, surgical or behavioral interventions in people and investigate novel approaches for the diagnosis and prevention / treatment of diseases. Clinicalresearch can be classified into two types: observational studies and clinicaltrials.
AI is increasingly important in drug discovery and development as well as clinicaltrials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI
Within Prime Patient, we have experts in patient strategy, clinicaltrial recruitment and patient education who are asked for their recommendations on the future of patient engagement by our clients as standard (see summaries). Rise of the machines – bigdata, AI and machine learning. VP, ClinicalTrial Recruitment.
The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and bigdata to spur better oncology R&D.
The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and bigdata to spur better oncology R&D.
Although approach differs slightly amongst organizations in clinicalresearch, everyone agrees on this: it’s time for the industry to become more agile. Too many life-saving treatments and medical advancements are at stake to remain attached to the traditional ways of data collection.
The Wall Street Journal has an interesting article on the use of “BigData” to identify and solicit potential clinicaltrial participants. The premise is that large consumer data aggregators like Experian can target patients with certain diseases through correlations with non-health behavior.
Clinicaltrials play a pivotal role in drug development. Time spent on clinicaltrials involves investment and being able to predict ADRs assists with improving the success rate. Clinicaltrials for different kinds of drugs often mandate differences in the patient pools. Embleema – Patient Advocacy.
XTALKS CLINICAL EDGE: Issue 2 — Genmab’s Interview Xtalks Clinical Edge is a magazine for clinicalresearch professionals and all who want to be informed about the latest trends and happenings in clinicaltrials. Celebrating 25 years of innovation is a significant milestone.
Introduction: A virtual clinicaltrial (also known as remote or decentralized clinicaltrials) in the definition refers to digitally empowered clinicaltrial processes. to conduct safe and improved clinicaltrialresearch. for the period 2020-2027 (Source: Polaris Market Research).
International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques.
The clinicaltrials landscape is evolving more rapidly than ever before. Meanwhile, decentralisation and the BigData revolution are transforming the way researchers run clinicaltrials, and previously untapped geographies are emerging as new hubs for future research.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content